Anniversary Sale Anniversary Sale


Cholesterol Guidelines Fraught With Massive Conflict of Interest

Ever wonder how the statin drugs ever became so popular? It is important to remember that the leader in this field, Lipitor, earns Pfizer TEN BILLION dollars every year. That can purchase enormous influence.

Pfizer and the other drug companies have some of the brightest marketing minds on the planet, after all they can afford them. Part of their strategy was to pay off some of the most well respected scientific leaders, the movers and shakers in the field, so they could influence the rest of the profession. And they were fabulously successful.

Conflicts of interest are increasingly common now that two-thirds of medical research at universities is funded by private industry. Twenty years ago, only one-third was. The drug industry spent $2 billion in 2001 on events for doctors - double what it spent five years earlier.

As this USA Today article points out 8 of the 9 leaders in this field that led influential medical groups, starred at prestigious meetings, published in top journals and were undisputed giants in their field, has massive conflict of interests. Eight of the nine were making money from the very companies whose cholesterol-lowering drugs they were urging upon millions more Americans.

  • Two own stock in them.
  • Two others went to work for drug companies shortly after working on the guidelines.
  • Another was a senior government scientist who moonlights for 10 companies and even serves on one of their boards.
If the blatant conflict of interest doesn't concern you then please read some of the science behind these drugs There clearly are better alternatives to taking these expensive and dangerous medications that in no way shape or form address the underlying cause of the problem that is typically related to insulin elevation.

USA Today October 16, 2004

Click Here and be the first to comment on this article
Post your comment